Kenneth C. Frazier, Director of Eikon Therapeutics EIKN, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $2M. The latest trade was on 03/02.

KF

KF

Kenneth C. Frazier

Director

Company

Eikon Therapeutics EIKN

First filing

26/02/06

Trades

2 trades

Buys / sales

1 / 0

12-month net buying

$2M

Last trade

03/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Eikon TherapeuticsEIKN	Open-market buy	02/04	02/06	111,111 sh	$18.00	$1,999,998	No record